Phathom Pharmaceuticals (NASDAQ:PHAT) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS
Phathom Pharmaceuticals (NASDAQ:PHAT – Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by ($0.01), FiscalAI reports. The company had revenue of $58.30 million during the quarter, compared to analyst estimates of $58.62 million. Here are the […]
1 May 00:18 · The Cerbat Gem